This product is a research grade chemical and not a pharmaceutical product. While the same active enantiomer (R-(−)-apomorphine) is an approved medicine, it is not manufactured, packaged, or regulated as a clinical dosage form, so it should not be used in humans.
A4393
R-(−)-Apomorphine hydrochloride hemihydrate
calcined, ≥98% (with NaOH, titration)
Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Voi/SKU | Disponibilità | Prezzo |
|---|
Informazioni su questo articolo
Formula condensata:
C17H17NO2 · HCl · 1/2H2O
Numero CAS:
Peso molecolare:
312.79
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352210
EC Number:
206-243-0
MDL number:
Assay:
≥98% (with NaOH, titration)
Form:
calcined, (Powder to Crystalline Powder)
Storage condition:
protect from light, under inert gas
Prezzi e disponibilità al momento non sono disponibili
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiQuality Segment
assay
≥98% (with NaOH, titration)
form
calcined, (Powder to Crystalline Powder)
storage condition
protect from light, under inert gas
color
white to gray
mp
285-287 °C (lit.)
solubility
H2O: ~10 mg/mL, clear, yellow-green
SMILES string
Cl[H].Cl[H].[H]O[H].[H][C@]12Cc3ccc(O)c(O)c3-c4cccc(CCN1C)c24.[H][C@]56Cc7ccc(O)c(O)c7-c8cccc(CCN5C)c68
InChI
1S/2C17H17NO2.2ClH.H2O/c2*1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12;;;/h2*2-6,13,19-20H,7-9H2,1H3;2*1H;1H2/t2*13-;;;/m11.../s1
InChI key
CXWQXGNFZLHLHQ-DPFCLETOSA-N
Gene Information
human ... DRD1(1812), DRD2(1813), DRD3(1814), DRD4(1815), DRD5(1816)
Application
Biochem/physiol Actions
R-(−)-Apomorphine acts as a non-selective D1 and D2 dopamine receptor agonist. It shows therapeutic effects against Parkinson′s disease and male erectile dysfunction. R-(−)-Apomorphine also shows neuroprotective, radical scavenging, and emetic effects. Apomorphine stimulates the brain chemoreceptor trigger zone. It stimulates the chemoreceptor trigger zone in the brain.
1 of 1
Questo articolo | |||
|---|---|---|---|
| description calcined, ≥98% (with NaOH, titration) | description Pharmaceutical Secondary Standard; Certified Reference Material | description United States Pharmacopeia (USP) Reference Standard | description powder, ≥98% (HPLC) |
| form calcined, (Powder to Crystalline Powder) | form solid | form - | form powder |
| assay ≥98% (with NaOH, titration) | assay - | assay - | assay ≥98% (HPLC) |
| Quality Level 200 | Quality Level 300 | Quality Level - | Quality Level 100 |
| solubility H2O: ~10 mg/mL, clear, yellow-green | solubility - | solubility - | solubility H2O: >10 mg/mL |
| storage condition protect from light, under inert gas | storage condition - | storage condition - | storage condition - |
| color white to gray | color - | color - | color white |
Parola di avvertenza
Danger
Codici di pericolo
Hazard Classifications
Acute Tox. 3 Oral
Classe di stoccaggio
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
Punto di infiammabilità (°F)
Not applicable
Punto di infiammabilità (°C)
Not applicable
DPI (dispositivi di protezione individuale)
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Avvertenze di sicurezza
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
-
How many doses in the 100mg bottle?
1 answer-
Helpful?
-